These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12620418)

  • 1. Anticancer bisquaternary heterocyclic compounds: a ras-ional design.
    Campos J; Núñez C; Díaz JJ; Sánchez RM; Gallo MA; Espinosa A
    Farmaco; 2003 Mar; 58(3):221-9. PubMed ID: 12620418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choline kinase inhibitors as a novel approach for antiproliferative drug design.
    Hernández-Alcoceba R; Saniger L; Campos J; Núñez MC; Khaless F; Gallo MA; Espinosa A; Lacal JC
    Oncogene; 1997 Nov; 15(19):2289-301. PubMed ID: 9393874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ChoK is an efficient antitumor strategy for Harvey-, Kirsten-, and N-ras-transformed cells.
    Ramírez de Molina A; Rodríguez-González A; Penalva V; Lucas L; Lacal JC
    Biochem Biophys Res Commun; 2001 Jul; 285(4):873-9. PubMed ID: 11467831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LUMO energy of model compounds of bispyridinium compounds as an index for the inhibition of choline kinase.
    Campos J; del Carmen Núñez M; Rodríguez V; Entrena A; Hernández-Alcoceba R; Fernández F; Lacal JC; Gallo MA; Espinosa A
    Eur J Med Chem; 2001 Mar; 36(3):215-25. PubMed ID: 11337100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New non-symmetrical choline kinase inhibitors.
    Schiaffino-Ortega S; López-Cara LC; Ríos-Marco P; Carrasco-Jimenez MP; Gallo MA; Espinosa A; Marco C; Entrena A
    Bioorg Med Chem; 2013 Nov; 21(22):7146-54. PubMed ID: 24080101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy.
    Ramírez de Molina A; Gutiérrez R; Ramos MA; Silva JM; Silva J; Bonilla F; Sánchez JJ; Lacal JC
    Oncogene; 2002 Jun; 21(27):4317-22. PubMed ID: 12082619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR-derived choline kinase inhibitors: how rational can antiproliferative drug design be?
    Campos J; Núñez MC; Conejo-García A; Sánchez-Martín RM; Hernández-Alcoceba R; Rodríguez-González A; Lacal JC; Gallo MA; Espinosa A
    Curr Med Chem; 2003 Jul; 10(13):1095-112. PubMed ID: 12678804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the linker in bispyridium compounds on the inhibition of human choline kinase.
    Conejo-García A; Báñez-Coronel M; Sánchez-Martín RM; Rodríguez-González A; Ramos A; Ramírez de Molina A; Espinosa A; Gallo MA; Campos JM; Lacal JC
    J Med Chem; 2004 Oct; 47(22):5433-40. PubMed ID: 15481981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline kinase: an important target for cancer.
    Janardhan S; Srivani P; Sastry GN
    Curr Med Chem; 2006; 13(10):1169-86. PubMed ID: 16719778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (Q)SAR studies to design new human choline kinase inhibitors as antiproliferative drugs.
    Campos JM; Sánchez-Martín RM; Conejo-García A; Entrena A; Gallo MA; Espinosa A
    Curr Med Chem; 2006; 13(11):1231-48. PubMed ID: 16712467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors.
    Rubio-Ruíz B; Conejo-García A; Ríos-Marco P; Carrasco-Jiménez MP; Segovia J; Marco C; Gallo MA; Espinosa A; Entrena A
    Eur J Med Chem; 2012 Apr; 50():154-62. PubMed ID: 22348828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homodimeric bis-quaternary heterocyclic ammonium salts as potent acetyl- and butyrylcholinesterase inhibitors: a systematic investigation of the influence of linker and cationic heads over affinity and selectivity.
    Conejo-García A; Pisani L; Núñez Mdel C; Catto M; Nicolotti O; Leonetti F; Campos JM; Gallo MA; Espinosa A; Carotti A
    J Med Chem; 2011 Apr; 54(8):2627-45. PubMed ID: 21417225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and in vitro antitumour activity of new heteroaryl ethylenes.
    Fortuna CG; Barresi V; Bonaccorso C; Consiglio G; Failla S; Trovato-Salinaro A; Musumarra G
    Eur J Med Chem; 2012 Jan; 47(1):221-7. PubMed ID: 22119128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Ras signalling to ChoK inhibitors: a further advance in anticancer drug design.
    Ramírez de Molina A; Rodríguez-González A; Lacal JC
    Cancer Lett; 2004 Apr; 206(2):137-48. PubMed ID: 15013519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells.
    Rodríguez-González A; Ramírez de Molina A; Fernández F; Ramos MA; del Carmen Núñez M; Campos J; Lacal JC
    Oncogene; 2003 Dec; 22(55):8803-12. PubMed ID: 14654777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of new bispyridinium salts of 4,4'-bispyridyl-5,5'-perfluoroalkyl-2,2'-bisoxazoles.
    Martín-Cantalejo Y; Sáez B; Monterde MI; Murillo MT; Braña MF
    Eur J Med Chem; 2011 Nov; 46(11):5662-7. PubMed ID: 21996467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery.
    Hernández-Alcoceba R; Fernández F; Lacal JC
    Cancer Res; 1999 Jul; 59(13):3112-8. PubMed ID: 10397253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, enzyme inhibition, and tumor cell growth inhibition of 2-anilinobenzamide derivatives as SIRT1 inhibitors.
    Suzuki T; Imai K; Imai E; Iida S; Ueda R; Tsumoto H; Nakagawa H; Miyata N
    Bioorg Med Chem; 2009 Aug; 17(16):5900-5. PubMed ID: 19616958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using molecular symmetry to form new drugs: hydroxymethyl-substituted 3,9-diazatetraasteranes as the first class of symmetric MDR modulators.
    Hilgeroth A; Molnár J; De Clercq E
    Angew Chem Int Ed Engl; 2002 Oct; 41(19):3623-5. 3516. PubMed ID: 12370910
    [No Abstract]   [Full Text] [Related]  

  • 20. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.